Literature DB >> 3280911

Topical and systemic antifungal agents.

G P Bodey1.   

Abstract

Superficial fungal infections are frequent and can cause considerable morbidity. Many topical agents are available that are effective against most of these infections. Systemic fungal infections are increasing in frequency, especially among immunocompromised hosts. Amphotericin B remains the most important therapeutic agents but is associated with significant acute and chronic toxicities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280911     DOI: 10.1016/s0025-7125(16)30763-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.

Authors:  G Dranitsaris; P Phillips; C Rotstein; A Puodziunas; S Shafran; G Garber; F Smaill; I Salit; M Miller; K Williams; J Conly; J Singer; S Ioannou
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

3.  Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.

Authors:  Joel B Epstein; Edmond L Truelove; Kimberly Hanson-Huggins; Lloyd A Mancl; Alice Chen; Oliver W Press; Stephen H Petersdorf; Thomas R Fritsche; Joshua D Epstein
Journal:  Support Care Cancer       Date:  2004-04-24       Impact factor: 3.603

Review 4.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

5.  Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.

Authors:  G M Scalarone; Y Mikami; N Kurita; K Yazawa; M Miyaji
Journal:  Mycopathologia       Date:  1992-12       Impact factor: 2.574

6.  Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.

Authors:  E Anaissie; V Paetznick; R Proffitt; J Adler-Moore; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.